Companies: 10,795·Total market cap: $144.5T

Celularity Inc.

Celularity Inc.

CELUNASDAQHealthcare● Active

$0.81

$-0.06(-6.92%)

Market Cap$19528914

P/E Ratio—

52W High$4.35

52W Low$0.71

Avg Volume220K

Open$0.88

Beta0.48

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Celularity Inc.（CELU）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CELU · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-3.69Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$26.6MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding25.6MShares outstanding history

Next EarningsAug 12, 2026Est.Earnings history

探索 Celularity Inc. 数据

分析师预测$3 · Buy

股息不分红

营收$26.6M-51.03%

盈利EPS $-3.59-35.75%

财务快照

FY 2025Revenue$26.6M▼ 51.03% YoY

202320242025

FY 2025Net Income-$91.8M▼ 58.57% YoY

202320242025

FY 2025EPS$-3.59▼ 35.75% YoY

202320242025

TTM:Revenue: $26.6MNet Income: -$91.7MEPS: $-3.69View income statement →

分析师评级与目标价

Buy6 位分析师

Strong Buy

0

Buy

3

Hold

2

Sell

1

Strong Sell

0

12-Month Price Target

$3.00Low

$0.81Current

$3.00Avg Target上涨空间 269.50%

$3.00High

合计: 6 · 买入占比: 50.0%

根据过去 3 个月内 6 位华尔街分析师，CELU 共识评级为 Buy，12 个月平均目标价 $3.00 （较现价 $0.81 上涨空间 269.50%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Celularity Inc.

$0.81-6.92%$19.5M #2

Annovis Bio, Inc.

$1.79-5.29%$35.2M #3

Actinium Pharmaceuticals, Inc.

$1.06-1.85%$33.3M #4

$3.31-0.60%$4.2M #5

BioXcel Therapeutics, Inc.

$1.11+0.00%$34.1M #6

$9.07-1.63%$36.7M

股票表现

1D-6.92%

1W-21.93%

1M-7.73%

3M-32.90%

YTD-26.86%

1Y-58.99%

5Y-99.20%

关于 Celularity Inc.

CEORobert Joseph Hariri

IPO DateAug 8, 2019

Employees120

CountryUS

Websitecelularity.com

Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments …

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Celularity Inc.（CELU）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 8, 2019 在 NASDAQ 上市。截至最近交易日，CELU 股价为 $0.81，市值约为 $19.5M。过去12个月累计回报 -58.99%，年初至今回报 -26.86%。

根据 6 位华尔街分析师，Celularity Inc. 股票共识评级为Buy，12个月平均目标价为 $3.00。2025 财年 Celularity Inc. 营收 $26.6M，净利润 -$91.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Celularity Inc.（CELU）股价为 $0.81，在 NASDAQ 上市，52周区间为 $0.71 – $4.35。

CELU 最新股价CELU quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议